A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia

Leukemia and Lymphoma

Volumn 31, Issue 3-4, 1998, Pages 343-349

  Maraninchi, Dominique ^a   Vey, Norbert ^a   Viens, Patrice ^a   Stoppa, Anne Marie ^a   Archimbaud, Eric ^f   Attal, Michel ^h   Baume, Daniel ^a   Bouabdallah, Reda ^a   Demeoq, Francois ^b   Fleury, Joel ^b   Michallet, Mauricette ^g   Olive, Daniel ^a   Reiffers, Josy ^c   Sainty, Daniele ^a   Tabilio, Antonio ^d   Tiberghien, Pierre ^e   Brandely, Maud ⁱ   Hercend, Thierry ⁱ   Blaise, Didier ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h CHU PURPAN   (France)

ⁱ SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 0032411004     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809059227     Document Type: Article

References (32)

1. Morgan, DA., Ruscetti, F.W. and Gallo, R.W. (1976) Selective in vitro growth of lymphocytes from normal human bone marrow. Science 193, 1007-1011.
2. Rosenberg, A., Lotze, M.T., Muul, L.M., Chang, A., Avis, F., Leitman, S., Linehan, M., Robertson, L., Lee, R., Rubin, J., Seipp, C., Simpson, C. and White, D. (1987) A progress report on the treatment of 157 patients with advanced cancer using activated killer cells and interleukine-2 or high dose interleukine-2 alone. N Engl J Med 316, 889-897.
3. Maraninchi, D., Biaise, D., Viens, P., Brandely, M., Olive, D., Lopez, M, Sainty, D., Marit, G., Stoppa, A.M., Reiffers, J., Gratecos, N., Bertau-Perez, P., Mannoni, P., Mawas, C., Hercend, T., Sebahoun, G. and Carcassonne, Y. (1991) High-dose recombinant interleukine-2 and acute myeloid leukemias in relapse. Blood 78, 2182-2187.
4. Foa, R., Meloni, G., Tosti, S., Novarino, A., Fenu, S., Gavosto, F. and Mandelli, F. (1991) Treatment of acute mye loid leukemia patients with recombinant Interleukin-2: a pilot study. Br J Hematol, 77, 491-496.
5. Lim, S.H., Newland, A.C., Kelsey, S., Bell, A., Offerman, E., Rist, C., Gozzard, D., Bareford, D., Smith, M.P. and Goldstone, A.H. (1992) Continuous intravenous infusion of high-dose recombinant Interleukin-2 for acute myeloid leukemia - a phase II study. Cancer Immunol Immunother, 34, 337-342.
6. Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C. and Storb, R. (1979) Antileukemic effect of graft versus host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300, 1068-1070.
7. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Ozman, C., Speck, B. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562.
8. Truitt, R.L., Lefever, A.V. and Shih, C.Y. (1988) Analysis of effector cells in the graft versus leukemia reaction and their relation to graft versus host disease. T-cell depletion in allogeneic bone marrow transplantation. In Proceedings Of The Serono Symposia. Ares-Serono Symposia, Rome, Italy, Edited by MF Martelli, F Grignani, Y Reisner, p 73.
9. Hercend, T., Takvorian, T., Nowill, A., Tantravahi, R., Moingeon, P., Anderson, K.C., Murray, C., Bohuon, C., Ythier, A. and Ritz, J. (1986) Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 67, 722-728.
10. Maraninchi, D., Gluckman, E., Biaise, D., Guyotat, D., Rio, B., Pico, J.L., Leblond, V., Michallet, M., Dreyfus, F., Ifrah, N., and Bordigoni, A. (1987) Impact of T-cell depletion on outcome of allogeneic bone marrow transplantation for standard risk leukemia. Lancet, 25, 175-176.
11. Kolb, H.J., Schattenberg, Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D. (1995) Graft versus leukemia effect of donor lymphocyte transfusion in marrow grafted patients. European Group of Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 56, 2041-2045.
12. Foa, R., Fierro, M.T., Cesano, A., Guarini, A., Bonferroni, M., Raspadori, D., Miniero, R., Lauria, F., Gavosto, F. (1991) Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease. Blood, 78, 1041-1046.
13. Archimbaud, E., Bailly, M., Doré, J.F. (1991) Inducibility of lymphokine-activated killer cells in patients with acute myelogenous leukemia in complete remission and its clinical relevance. Br J Haematol, 77, 328-334.
14. Foa, R., Fierro, M.T., Tosti, S., Meloni, G., Gavosto, F. and Mandelli, F. (1990) Induction and persistence of complete remission in a resistant acute myeloid leukemia patient after treatment with recombinant Interleukin-2. Leukemia and Lymphoma, 1, 113-117.
15. Meloni, G., Foa, R., Vignetti, M., Guarini, A., Fenu, S., Tosti, S., Tos, A.G. and Mandelli, F. (1994) Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood 84, 2158-2163.
16. Bennett, J.M., Catovsky, D., Daniel, M.T., Flanrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan C. (1976) Proposal for the classification of the acute leukemia. Br J Hematol, 33, 451-458.
17. Cheson, B.D., Cassileth, P.A., Head, D.R, Schiffer, C.A., Bennett, J.M., Bloomfield C.D., Brunning, R., Gale, R.P., Greever, M.R., Keating, M.J., Sawitsky, A., Stass, S., Weins tein, H. and Woods, W.G. ( 1990) Report of the National Cancer Institute-sponsored Workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8, 813-819.
18. Preisler, H.D. (1982) Treatment failure in AML. Blood Cells 8, 585-602.
19. Hawkins M.J. (1993) Interleukin-2 antitumor and effector cell responses. Sem Oncol 6 (suppl 9), 52-59.
20. Olive, D., Chambost, H., Sainty, D., Stoppa, A.M., Biaise, D., El Marsafy, S., Brandely, M., Mannoni, P., Mawas, C. and Maraninchi, D. (1994) Modifications of leukemic blast cells induced by in vivo high-dose recombinant Interleukin-2. Leukemia, 8, 1230-1235.
21. Attal, M., Biaise, D., Marit, G., Payen, C., Michallet, M., Vernant, J.P., Sauvage, C., Troussard, X., Nedellec, G., Pico, J., Guguet, F., Stoppa, A.M., Broustet, A., Sotto, J.J., Pris, J., Maraninchi, D. and Reiffers, J. (1995) Consolidation treatment of adult acute lymphoblastic leukemia: A prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. Blood, 86, 1619-1628.
22. Baumgarten, E., Schmid, H., Pohl, U., Brzoska, J., Linderkamp, C., Siegert, W. and Henze, G. (1994) Low-dose natural interleukin-2 and recombinant Interferon-Gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia, 8, 850-855.
23. Biaise, D., Attal, M., Pico, J.L., Reiffers, J., Stoppa, A.M., Bellanger, C., Molina, L., Nedellec, G., Vernant, J.P., Legros, M., Gabus, R., Huguet, F., Brandely, M., Hercend, T., Olive, D. and Maraninchi, D. (1997) The use of a sequential high-dose recombinant Interleukin-2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission. Leuk and Lymph, 25, 469-478.
24. Foa, R. (1993) Does Interleukin-2 have a role in the management of acute leukemia? J. Clin. Oncol. 11, 1817-1825.
25. Singer, C.R.J., Tansey, P.J. and Burnett, A.K. (1983) T lymphocyte reconstitution following autologous bone marrow transplantation. Clin Exp Immunol, 51, 455-460.
26. Charmot, D., Ragueneau, M., Olive, D., Maraninchi, D. and Mawas, C. (1987) Generation of CD8 cytolytic T-cells early after autologous or allogeneic bone marrow transplantation. Bone Marrow Transplantation, 2, 183-194.
27. Reittie, J.E., Gottlieb, D., Heslop, H.E., Leger, O., Drexler, H.G., Hazlehurst, G., Hoffbrand, A.V., Prentice, H.G. and Brenner, M.K. (1989) Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood, 73, 1351-1358.
28. Higuchi, CM., Thompson, J.A., Cox, T., Lindgren, C.G., Buckner, C.D. and Fefer, A. (1989) Lymphokin-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies. Cancer Res, 49, 5509-5513.
29. Hercend, T., Takvorian, T., Nowill, A., Tantravahi, R., Moingeon, P., Anderson, K.C., Murray, C., Bohuon, C., Ythier, A. and Ritz, J. (1986) Characterization of Natural Killer cells with Antileukemia Activity Following Allogeneic Bone Marrow Transplantation. Blood, 67, 722-728.
30. Biaise, D., Olive, D., Stoppa, A.M., Fourreau, C., Lopez, M., Attal, M., Jasmin, C., Monges, G., Mawas, C., Mannoni, P., Palmer, P., Francks, C., Philip, T. and Maraninchi, D. (1990) Hematologic and immunologic effects of the systemic administration of recombinant Interleukin-2 after autologous bone marrow transplantation. Blood, 76, 1092-1097.
31. Benyunes, M.C., Massumoto, C., York, A., Higushi, C.M., Buckner, C.D., Thompson, J.A., Petersen, F.B., and Fefer, A. (1993) Interleukin-2 with or without lymphokin-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant, 12, 159-163.
32. Hamon, D., Prentice, H.G., Gottlieb, D.J., MacDonald, I.D., Cunningham, J.M., Smith, O.P., Gilmore, M., Gandhi, L., Collis, C. (1993) Preliminary report. Immunotherapy with interleukin-2 after ABMT in acute myelogenous leukemia. Bone Marrow Transplant, 11, 399-401.